EE03306B1 - Use of alendronate to prevent osteoporosis - Google Patents

Use of alendronate to prevent osteoporosis

Info

Publication number
EE03306B1
EE03306B1 EE9700308A EE9700308A EE03306B1 EE 03306 B1 EE03306 B1 EE 03306B1 EE 9700308 A EE9700308 A EE 9700308A EE 9700308 A EE9700308 A EE 9700308A EE 03306 B1 EE03306 B1 EE 03306B1
Authority
EE
Estonia
Prior art keywords
alendronate
prevent osteoporosis
osteoporosis
prevent
Prior art date
Application number
EE9700308A
Other languages
Estonian (et)
Inventor
John Yates A.
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE03306B1 publication Critical patent/EE03306B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9700308A 1995-06-02 1996-05-29 Use of alendronate to prevent osteoporosis EE03306B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (1)

Publication Number Publication Date
EE03306B1 true EE03306B1 (en) 2000-12-15

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700308A EE03306B1 (en) 1995-06-02 1996-05-29 Use of alendronate to prevent osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (en)
JP (1) JPH10506648A (en)
KR (1) KR19990022436A (en)
CN (1) CN1192685A (en)
AU (1) AU709196B2 (en)
BG (1) BG63103B1 (en)
BR (1) BR9609020A (en)
CA (1) CA2222318A1 (en)
CZ (1) CZ381197A3 (en)
EA (1) EA000677B1 (en)
EE (1) EE03306B1 (en)
HU (1) HUP9900659A3 (en)
IL (1) IL118422A0 (en)
IS (1) IS4617A (en)
NO (1) NO975527D0 (en)
NZ (1) NZ308935A (en)
PL (1) PL323669A1 (en)
SK (1) SK159597A3 (en)
TR (1) TR199701482T1 (en)
WO (1) WO1996038156A1 (en)
ZA (1) ZA964465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
JP2004528365A (en) * 2001-05-02 2004-09-16 ノバルティス アクチエンゲゼルシャフト Inhaled bisphosphonate administration method for treatment or prevention of bone resorption and osteoporosis
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
KR102472749B1 (en) * 2022-01-18 2022-12-02 주식회사 위엔씨 Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
NO975527L (en) 1997-12-01
EP0828496A1 (en) 1998-03-18
EA000677B1 (en) 2000-02-28
HUP9900659A3 (en) 2002-12-28
IL118422A0 (en) 1996-09-12
BR9609020A (en) 1999-07-06
HUP9900659A2 (en) 2001-04-28
CN1192685A (en) 1998-09-09
ZA964465B (en) 1996-12-11
AU709196B2 (en) 1999-08-26
WO1996038156A1 (en) 1996-12-05
KR19990022436A (en) 1999-03-25
SK159597A3 (en) 1998-06-03
NO975527D0 (en) 1997-12-01
CZ381197A3 (en) 1998-06-17
IS4617A (en) 1997-11-19
JPH10506648A (en) 1998-06-30
NZ308935A (en) 2000-07-28
AU5882496A (en) 1996-12-18
TR199701482T1 (en) 1998-03-21
EA199700449A1 (en) 1998-06-25
BG63103B1 (en) 2001-04-30
PL323669A1 (en) 1998-04-14
BG102060A (en) 1998-07-31
CA2222318A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
FR2729849B1 (en) ADHESIVE PLASTER
DE59604607D1 (en) JOINTLESS PROSTHESIC FOOT PART
DK0861235T3 (en) Substituted benzylaminopiperidine compounds
DE69634256D1 (en) CEMENT FORMULATION
DE69607031D1 (en) CLEANSER
ATA181095A (en) PROBIOTALLY EFFECTIVE FORMULATION
BR9607427A (en) Inhibition of angiogenes using interleukin 12
IT1276799B1 (en) FORMULATIONS OF F-SILICONE
EE03306B1 (en) Use of alendronate to prevent osteoporosis
FI952707A (en) Preheater water preheater system
ATA93795A (en) FIXING TIES
NO964685L (en) Isomization of equilin
PT761766E (en) ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE
KR960031589U (en) End Connection of Footpath Boundary Stone
KR960033296U (en) Bathroom shoes
AT204U3 (en) FOOT SCRAPER
KR970015931U (en) Detachable shoes
KR970000111U (en) 3rd phase transfer of the metropolitan equipment system
KR970000149U (en) Bathroom shoes
KR970011853U (en) New form of maryas
ITMI951551A0 (en) OROSOLUBLE COMPOSITIONS OF N-ACETYLCISTEINE
KR970010637U (en) Switchgear of water distributor
ITMI950803A0 (en) LACTONE COMPOUNDS USEFUL FOR THE TREATMENT OF OSTEOPOROSIS
ITMI950804A0 (en) LACTONE COMPOUNDS USEFUL FOR THE TREATMENT OF OSTEOPOROSIS
KR970014191U (en) Structure of fastening boss

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

MM4A Lapsed by not paying the annual fees

Effective date: 20030529